Aurobindo Pharma Limited (BOM:524804)
India · Delayed Price · Currency is INR 1,223.65
+15.55 (1.29%)
At close: Dec 4, 2025
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 707.18 billion as of December 5, 2025. Its market cap has decreased by -1.44% in one year.
Market Cap
707.18B
Enterprise Value
696.13B
Revenue
325.14B
Ranking
n/a
PE Ratio
20.66
Stock Price
1,223.65
Market Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 707.18B, an increase of 7,263.99%. That is a compound annual growth rate of 20.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 707.18B | -8.76% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | 539.83B | 101.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 20.78T |
| HDFC Bank | 15.34T |
| Bharti Airtel | 12.61T |
| Tata Consultancy Services | 11.68T |
| ICICI Bank | 9.91T |
| State Bank of India | 8.75T |
| Infosys | 6.62T |
| Bajaj Finance | 6.39T |